Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

  • First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery
  • Published:

Liver resection for hepatocellular carcinoma: results from 150 consecutive patients

  • 15 Accesses

  • 26 Citations


During the past 6 years, 150 consecutive hepatic resections were performed for hepatocellular carcinoma on 129 male and 21 female patients. Their ages ranged from 17 years to 78 years, with an average of 57.0 years. All but two patients had an underlying parenchymal disease of the liver; 131 had liver cirrhosis, 16 chronic hepatitis, and one liver fibrosis. The operations performed were extended right lobectomy in 10cases, right lobectomy in 13, left lobectomy in 5, left lateral segmentectomy in 11, other segmentectomies in 31, and partial wedge resection in 80 instances. The operative and in-hospital mortality rates were 6.0% and 12.0% respectively. In the 122 patients with curative resection, the 1-, 3- and 5-year survival rates were 75.2%, 49.0% and 30.0% respectively. The 1- and 3-year survival rates were 14.3% and 7.1% in the 28 patients with palliative resection. The tumor size and Child's classification generally reflected the survival rate.

This is a preview of subscription content, log in to check access.


  1. 1.

    Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH (1978) The morphology of cirrhosis:recommendations on definition, nomenculature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 31: 395

  2. 2.

    Bengmark S, Hafstrom L, Jeppsson B, Sundqvist K (1982) Primary carcinoma of the liver: improvement in sight? World J Surg 6: 54

  3. 3.

    Blumgart LH, Brury JK, Wood CB (1979) Hepatic resection for trauma, tumour and biliary obstruction. Br J Surg 66: 762

  4. 4.

    Curutchet HP, Terz JJ, Kay S, Lawrence W Jr (1971) Primary liver cancer. Surgery 70: 467

  5. 5.

    Epirubicin Study Group for Hepatocellular Carcinoma (1978) Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 19: 183

  6. 6.

    Fortner JG, Kim DK, MacLean BJ, Barrett MK, Iwatsuki S, Turnbull AD, Hawland WS, Beattie EJ (1978) Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg 188: 363

  7. 7.

    Harrison NW, Dhru D, Primack A, Bhana D, Kyalwazi SK (1973) The surgical management of primary hepatocellular carcinoma in Uganda. Br J Surg 60: 565

  8. 8.

    Iwatsuki S, Shaw BW Jr, Starzl TE (1983) Experience with 150 liver resections. Ann Surg 197: 247

  9. 9.

    Lee NW, Wong J, Ong GB (1982) The surgical management of primary carcinoma of the liver. World J Surg 6: 66

  10. 10.

    Inouye AA, Whelar TJ (1979) Primary liver cancer: A review of 205 cases in Hawaii. Am J Surg 138: 53

  11. 11.

    Lin TY (1979) Resectional therapy for primary malignant hepatic tumors. Int Adv Surg Oncol 2: 25

  12. 12.

    Nagasue N, Yukaya H, Suehiro S, Ogawa Y (1984) Tolerance of the cirrhotic liver to normothermic ischemia: a clinical study of 15 patients. Am J Surg 147: 772

  13. 13.

    Nagasue N, Yukaya H, Ogawa Y, Akamizu H, Kimura N, Takahashi M (1984) Diagnosis and treatment of minute hepatocellular carcinoma in the cirrhotic liver: report of 21 cases. Chir Epatobil 3: 11

  14. 14.

    Nagasue N, Ogawa Y, Yukaya H, Hirose S (1985) Modified distal splenorenal shunt with expanded polytetrafluoroethylene interposition. Surgery 98: 870

  15. 15.

    Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Akamizu H, Hamada T (1985) Hepatic resection in the treatment of hepatocellular carcinoma: report of 60 cases. Br J Surg 72: 292

  16. 16.

    Nagasue N, Yukaya H, Ogawa Y, Hirose S, Okita M (1985) Segmental and subsegmental resections of the cirrhotic liver under hepatic inflow and outflow occlusion. Br J Surg 72: 565

  17. 17.

    Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang Y-C, Niimi K (1986) Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 99: 694

  18. 18.

    Nagasue N, Yukaya H, Chang Y-C, Ota N, Kimura N, Nakamura T (1987) Appraisal of hepatic resection in the treatment of minute hepatocellular carcinoma associated with liver cirrhosis. Br J Surg 74: 836

  19. 19.

    Okamura J, Horikawa S, Fujiyama T, Monden M, Kambayashi J, Sikujara O, Sakurai M, Kuroda C, Nakamura H, Kosaki G (1982) An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg 6: 352

  20. 20.

    Olweny CLM, Toya T, Katongole-Mbidde E, Mugerwa J, Kyalwazi SK, Cohe H (1975) Treatment of hepatocellular carcinoma with adriamycin. Cancer 36: 1520

  21. 21.

    Warren WD, Zeppa R, Fomon JJ (1967) Selective transsplenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 166: 437

Download references

Author information

Correspondence to Naofumi Nagasue.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nagasue, N., Yukaya, H. Liver resection for hepatocellular carcinoma: results from 150 consecutive patients. Cancer Chemother. Pharmacol. 23, S78–S82 (1989).

Download citation


  • Hepatitis
  • Survival Rate
  • Hepatocellular Carcinoma
  • Chronic Hepatitis
  • Liver Cirrhosis